Abstract
Background

B.
he U nited States Pharmacopeia (USP) has recently included a new dissolution apparatus (Apparatus 3) for drug release testing as an alternative method to the now classical basket and paddle appa ratus. US P cond ucted a coll aborative snldy to establish tile system suitabi li ty limits for two new ca libra to rs that are now availab le for usc: US P C hlorph eniramin e Extended-release T..blets (Drug Release Ca librator, single unit) and USP Theophylline Extendedrelease Beads (Drug Release Ca li brator, multiple unit. The USP protocol sheet for e.lch ca li brator includes acceptance ranges whi ch were reviewed and approved by the USP Subcolllm ittee on Dissolution, T he fl exibi li ty of the apparatus is a positive attribute for pharmaceutical scientists engaged in the quality assessment of contro ll ed release delivery syste ms and /o r the development of in vitro -in vivo correlations which might serve as su rrogates for bioequivalence testing. However, with increased fl exibi li ty comes increased comp lexity making ca libratio n and va lidation of the apparatus a cha ll enge.
Despite the fact that the apparatus has a multiple row design, the Appara tus Suitabi li ty Test for both ca li brators is conducted by sam pling from vessels in a si ngle row. The aim of this brief study was to compare two ca librato rs [e.g., USP
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C hl o rph cniramin e E xtend ed -release T1 bl ets (Drug Release C llibrator, sin gle unit) and US P Th eophyllin e Extended-re lease Beads (Drug Rel ease Ca librator, multiple unit)J in Apparatus 3 usin g single and multipl e row procedures.
Experimental
C hl o rph eniramin e Extended-release u lblets (Drug Release C alibrator, sin gle unit) and US P Theoph yllin e Extended-re lease Beads (Drug Release C alibrato r, mul tipl e unit) we re anal yzed usin g USP Apparatus 3 (VanKel BIO-DIS), under the conditions summarized in l~lbl e l.
Apparatu s 3 (VanKe l BIO-DIS Extended
Release Tester) W<1 S set lip accordin g to th e manufacturers specifications. Th e sampl e cells were asse mbl ed as specifi ed with a 20 mes h, 0.84 I11Jll sta inl ess steel scree n o n the bo tto m of each of the reciprocating cylinders and no sc ree n on top. After the tes t sample (beads o r tablet) was weighed and placed in the dry cell , the top of the cylinder was secured and th en t he asse mbl y was atta ched to the appropriate reciprocating rod.
Th e di ssolution medium in th ese tes ts was wa rm ed to 37°C and degassed (s tirrin g under va cuum) for at lerl st 10 minutes prior to instrum ent set-up. To kee p the temperature o f the medium in th e vessels at 37°C the wate r ba th te mperature co ntro ll er was set to 37 .5°C . An injtial vo lume o f 25 0 mL of the warm degassed medium was placed in each cylindri cal vessel, and the vessel was th en placed in the apparauls. At th e compl etion o f t hi s o perati o n, the retractable plas ti c cover was secured in place coverin g all th e vessels exce pt th ose in the active row. A), where on ly a si ngle row o f the apparatus is utili zed. Also included arc resul ts for the tests conducted by utilizing two rows of vessels (Graph B), with CXp OSlU·C times guided by the test criteria .
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Figures 4-5 ;1lso summarize the data, in this case represe n tin g the release res ults for the Theophylline beads and Ch lorph e nira min e Ma leate tablets as ave ra ge va lues for the six Dim/lltionTecbll%giesl AUGUST 1997 replicates plotted aga inst ti me, and including the limits of the Apparan,s Suitability Test.
Conclusions
Data from single and multiple row experiments in USP Dissolution Apparatus 3 demonstrate that both calibrators fall within specified US P limi ts. However, for all calibrators under all co nditions t h e % di ssolved at a particular time point is g reater when the experin"len t is conducted by moving the sample chambe rs to a new row, This result is consistent with the establishment of sink conditio ns (e.g., no di ssolved drug) when the sampl es are moved to th e second row, Also, results calculated from t he sin g le row test did not show as much cell to cell va ri atio n as compared to the results from test runs using two rows. At 30 DPM , a Ibss of approxima tely 15-18 m ls of dissolutio n media, a ppare ntl y th.rough th e air holes, was observed.
[n some instances, ca librator tab lets were found to be adherin g to th e screen at 5 DPM using the single row.
These concl usio ns are based on limited data, and morc testing is required to compl ete ly c haracteri ze the performance of Apparatus 3. It is unlikely t hat the current Appa ratus Su itabi li ty Test is sufficient in this regard, and USP should give consideratio n to designing and conducti ng a coll abo rative, multi-lab stud y that includes multiple row testing.
